Targeting NKp46 boosts immune response, Innate Pharma believes

In the bid to develop drugs to boost the immune system and fend off various infections, NKp46 may be the next big target. NKp46 is a receptor that helps regulate the immune system's natural killer cells. But mice bred to not express this key receptor displayed stronger natural killer cells and fought off certain viral infections more effectively, Bloomberg reports. Credit scientists at French drug developer Innate Pharma with making the finding, which is detailed in the journal Science. Innate and French research institute Inserm have filed patent applications based on their discovery, the intellectual property rights of which they co-own, according to the article. Story